ACM Research, Inc. ACMR used its Q2 2026 call to emphasize stronger orders, new-product commercialization and firmer full-year visibility. First-half orders rose 105% year over year, with greater weight from newer products, while management raised the low end of the 2026 revenue guidance.

Revenues rose 36% to $292.9 million, which topped the Zacks Consensus Estimate of $268.2 million. Non-GAAP EPS came in at $0.61, ahead of the Zacks Consensus Estimate of $0.3.

Originally published on zacks.com, part of the BLOX Digital Content Exchange.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.